Edition:
United Kingdom

Adamas Pharmaceuticals Inc (ADMS.OQ)

ADMS.OQ on NASDAQ Stock Exchange Global Market

10.07USD
8:59pm GMT
Change (% chg)

$-0.75 (-6.93%)
Prev Close
$10.82
Open
$10.64
Day's High
$10.64
Day's Low
$9.98
Volume
210,980
Avg. Vol
182,094
52-wk High
$43.98
52-wk Low
$9.98

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Gregory Went

54 2000 Chairman of the Board, Chief Executive Officer, Co-Founder

Alfred Merriweather

64 2017 Chief Financial Officer

Christopher Prentiss

43 2017 Chief Accounting Officer

Jennifer Rhodes

48 2016 Chief Compliance Officer, General Counsel, Corporate Secretary, Chief Business Officer

Rajiv Patni

49 2015 Chief Medical Officer